Acriflavine

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAcriflavine
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHypoxia-inducible factor prolyl hydroxylase inhibitorsLysyl oxidase inhibitors
TargetsHypoxia-inducible factor prolyl hydroxylaseLysyl oxidase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDebiopharm GroupInserm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDebiopharm GroupInserm
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A